Multiple Sclerosis

Oversight Committee Members

• Fred Lublin, MD
  Mount Sinai Medical Center, New York, New York
  Chair
• Douglas Arnold, MD
  McGill University, Montreal, Canada
• Ralph Benedict, PhD
  University at Buffalo, Buffalo, New York
• Peter S. Chin, MD, MSHS
  Genentech-Roche, San Francisco, California
• Gary Cutter, PhD
  The University of Alabama at Birmingham School of Public Health, Birmingham, Alabama
• Robert J. Fox, MD, FAAN
  Neurological Institute, Cleveland Clinic, Cleveland, Ohio
• Gordon Francis, MD
  Novartis Pharmaceuticals, San Francisco, California
• Mark Freedman, MD, CSPQ, FAAN, FRCP(C)
  Ottawa Hospital Research Institute, Ottawa, Canada
• Deborah Hertz, MPH
  National Multiple Sclerosis Society, New York, New York (until 2018)
• Mary Hughes, MD
  Augusta MS Center, Augusta, Georgia
• Nicholas LaRocca, PhD
  National Multiple Sclerosis Society, New York, New York
• Ruth Ann Marrie, MD, PhD, FRCP(C)
  University of Manitoba, Winnipeg, Canada
• Penny Pennington, MAS
  Advancing Research in MS, Buffalo, New York
• Richard Rudick, MD
  Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio (until 2018)

Working Group Co-Chairs

• Fred Lublin, MD
  Mount Sinai Medical Center, New York, New York
• Chris Polman, MD, PhD
  VU University Medical Center Amterdam, Amsterdam, The Netherlands

Biospecimens

• Gordon Francis, MD
  Novartis Pharmaceuticals, San Francisco, California
• Philip de Jager, MD, PhD
  Brigham and Women's Hospital, Boston, Massachusetts
• Suhayl Dhib-Jalbut, MD
  Robert Wood Johnson Medical School, New Brunswick, New Jersey
• Steven Jacobson, PhD
  National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, Maryland
• Jens Kuhle, MD
  University Hospital of Basel, Basel, Switzerland
• Jorge Oksenberg, PhD
  University of California San Francisco, San Francisco, California
• Michael Racke, MD
  The Ohio State University Medical Center, Columbus, Ohio

Demographics and Clinical Assessments

• Howard Weiner, MD
  Brigham and Women's Hospital, Boston, Massachusetts
  Chair

Demographics and Clinical Assessments (Demographics and Medical History)

• Richard Rudick, MD
  Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio
  Vice Chair
• Brenda Banwell, MD
  The Hospital for Sick Children, University of Toronto, Toronto, Canada
• Tanuja Chitnis, MD
  Brigham and Women's Hospital, Boston, Massachusetts
• Christian Confavreux, MD
  H?pital Neurologique Pierre Wertheimer, Bron, France
• Yossi Gilgun-Sherki, PhD
  Teva Pharmaceuticals Industries Ltd, Petah Tikva, Israel
• Deborah Hertz, MPH
  National Multiple Sclerosis Society, New York, New York
• Annette Langer-Gould, MD
  Kaiser Permanente Department of Research & Evaluation, Pasadena, California
• Ruth Ann Marrie, MD, PhD, FRCP(C)
  University of Manitoba, Winnipeg, Canada
• Luanne Metz, MD, FRCP
  University of Calgary, Calgary, Canada
• Daniel Mikol, MD, PhD
  Amgen, Thousand Oaks, California
• William Pryse-Phillips, MD
  Memorial University of Newfoundland, St. John's, Canada
• Dessa Sadovnick, PhD
  University of British Columbia, Vancouver, Canada
• Leslie Weiner, MD
  Keck School of Medicine of University of Southern California, Los Angeles, California

Demographics and Clinical Assessments (Laboratory Tests and Non-Imaging Diagnostics)

• Bibiana Bielekova, MD
  National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, Maryland
  Vice Chair
• Jack Antel, MD
  McGill University, Montreal, Canada
• Patricia Coyle, MD
  State University of New York at Stony Brook, Stony Brook, New York
• Anne Cross, MD
  Washington University School of Medicine, St. Louis, Missouri
• Mark Freedman, MD, CSPQ, FAAN, FRCP(C)
  Ottawa Hospital Research Institute, Ottawa, Canada
• Robert Lisak, MD, FAAN, FRCP
  Wayne State University School of Medicine, Detroit, Michigan
• John Richert, MD
  Business Partner-MD, Henderson, Nevada

Demographics and Clinical Assessments (Outcomes and Neurological/Physical Exam)

• Stephen Hauser, MD
  University of California San Francisco, San Francisco, California
  Vice Chair
• Peter S. Chin, MD, MSHS
  Genentech-Roche, San Francisco, California
• Michel Clanet, MD
  Hospital Center University Toulouse, Toulouse, France
• Jeffrey Cohen, MD
  Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio
• Jenny Freeman, PhD
  University of Plymouth, Plymouth, United Kingdom
• Ludwig Kappos, MD
  University Hospital of Basel, Basel, Switzerland
• Aaron Miller, MD
  Mount Sinai School of Medicine, New York, New York
• Xavier Montalban, MD
  Hospital Universitari Vall D'Hebron, Barcelona, Spain
• Paul O'Connor, MD
  University of Toronto, Toronto, Canada
• Stephen Reingold, PhD
  Scientific and Clinical Review Associates LLC, Salisbury, Connecticut
• Per Soelberg Sorensen, MD, DMsc, FAAN
  Copenhagen University Hospital, Kobenhavn, Denmark
• Emmanuelle Waubant, MD, PhD
  University of California San Francisco, San Francisco, California

Imaging

• Jerry Wolinsky, MD
  University of Texas Health Science Center at Houston, Houston, Texas
  Chair
• Douglas Arnold, MD
  McGill University, Montreal, Canada
• Laura Balcer, MD, MSCE
  Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
• Frederik Barkhof, MD
  VU Medical Center Amsterdam, Amsterdam, The Netherlands
• Massimo Filippi, MD
  University Ospedale San Raffaele, Milano, Italy
• Elizabeth Fisher, PhD
  Cleveland Clinic Lerner Research Institute, Cleveland, Ohio
• Volker Knappertz, MD
  Teva Pharmaceuticals Industries Ltd, Philadelphia, Pennsylvania
• David Miller, MD
  UCL Institute of Neurology, London, United Kingdom
• Jack Simon, MD
  Oregon Health and Sciences University, Portland, Oregon

Neuropsychology/Cognition

• Ralph Benedict, PhD
  University at Buffalo, Buffalo, New York
  Chair
• Maria Pia Amato, MD
  University of Florence, Florence, Italy
• Gordon Francis, MD
  Novartis Pharmaceuticals, San Francisco, California
• Laura Julian, PhD
  University of California San Francisco, San Francisco, California
• Lauren Krupp, MD
  Stony Brook University Hospital, Stony Brook, New York
• Dawn Langdon, PhD
  Royal Holloway, University of London, Egham, United Kingdom
• Nicholas LaRocca, PhD
  National Multiple Sclerosis Society, New York, New York
• Stephen Rao, PhD
  Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio
• Christine Till, PhD, Cpsych
  York University, Toronto, Canada

Operations/Special Advisors

• Timothy Coetzee, PhD
  National Multiple Sclerosis Society, New York, New York
• Gary Cutter, PhD
  The University of Alabama at Birmingham School of Public Health, Birmingham, Alabama
• George Ebers, MD
  University of Oxford, Oxford, United Kingdom
• Maria Pia Sormani, PhD
  University of Genoa, Genova, Italy

NINDS CDE Team

• Robin Conwit, MD
  National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, Maryland
• Codrin Lungu, MD
  National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, Maryland
• M. Carolina Mendoza-Puccini, MD
  NINDS CDE Program Officer, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, Maryland
• Claudia S. Moy, PhD
  National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, Maryland
• Joanne Odenkirchen, MPH
  NINDS CDE Project Officer, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, Maryland
• Ursula Utz, PhD, MBA
  National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, Maryland
• Sherita Ala'i Hansen, MS (Until 2018)
  The Emmes Company, LLC, Rockville, Maryland
• Ilar Edun, BA (Until 2020)
  The Emmes Company, LLC, Rockville, Maryland
• Joy Esterlitz, MS (Until 2020)
  The Emmes Company, LLC, Rockville, Maryland
• Robin Feldman, BS, MBA
  The Emmes Company, LLC, Rockville, Maryland
• Katelyn Gay, BS
  The Emmes Company, LLC, Rockville, Maryland
• Stacie Grinnon, MS
  KAI Research, Inc. (An Altarum Company), Rockville, Maryland
• Megan Schmidt
  KAI Research, Inc. (An Altarum Company), Rockville, Maryland
• Alexandra Stout
  KAI Research, Inc. (An Altarum Company), Rockville, Maryland